NPI: 1316983158 · SEATTLE, WA 98134 · Clinical Medical Laboratory · NPI assigned 06/21/2006
Authorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
| Authorized Official | BOWLES, CHARLES (VICE PRESIDENT) |
| Parent Organization | QUEST DIAGNOSTICS INCORPORATED |
| NPI Enumeration Date | 06/21/2006 |
Other providers sharing the same authorized official: BOWLES, CHARLES
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,175,567 | $11.53M |
| 2019 | 1,371,326 | $14.44M |
| 2020 | 1,059,156 | $13.00M |
| 2021 | 1,347,617 | $18.26M |
| 2022 | 1,406,705 | $18.49M |
| 2023 | 1,463,428 | $16.63M |
| 2024 | 1,374,009 | $16.87M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 119,947 | 113,126 | $8.46M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 213,985 | 203,443 | $5.27M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 214,266 | 203,751 | $5.25M |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 11,970 | 10,262 | $5.02M |
| 80050 | General health panel | 210,016 | 205,499 | $4.76M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 77,344 | 62,811 | $4.50M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 119,197 | 92,414 | $4.48M |
| 80053 | Comprehensive metabolic panel | 563,818 | 533,741 | $3.44M |
| 80061 | Lipid panel | 421,328 | 407,298 | $3.39M |
| 84443 | Thyroid stimulating hormone (TSH) | 317,925 | 307,147 | $2.94M |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 169,320 | 165,332 | $2.66M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 460,928 | 427,754 | $2.04M |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 37,115 | 35,861 | $1.81M |
| 86003 | 75,687 | 24,710 | $1.64M | |
| 86480 | 43,554 | 40,735 | $1.63M | |
| 86803 | 172,482 | 168,018 | $1.61M | |
| 83036 | Hemoglobin; glycosylated (A1C) | 297,065 | 286,153 | $1.58M |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 64,331 | 62,487 | $1.49M |
| 36415 | Collection of venous blood by venipuncture | 642,462 | 580,330 | $1.42M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 131,186 | 124,848 | $1.39M |
| 80081 | 26,975 | 26,110 | $1.38M | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 54,890 | 53,737 | $1.31M |
| 82728 | 158,748 | 153,353 | $1.29M | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 221,015 | 208,659 | $1.22M |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 63,356 | 62,264 | $1.18M |
| 87902 | 6,802 | 6,451 | $1.13M | |
| 83013 | 23,537 | 23,187 | $1.09M | |
| 82607 | 103,548 | 99,907 | $915K | |
| 87088 | 173,123 | 164,150 | $906K | |
| 84403 | 55,456 | 52,965 | $873K | |
| 87522 | Neg quan hep c or qual rna | 30,351 | 28,989 | $868K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 48,397 | 45,401 | $813K |
| 84439 | 123,630 | 118,947 | $679K | |
| 87510 | 48,441 | 46,694 | $665K | |
| 87480 | 48,491 | 46,739 | $664K | |
| 82746 | 76,039 | 73,385 | $653K | |
| 87660 | 48,478 | 46,727 | $645K | |
| 87799 | 27,754 | 10,849 | $617K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 1,738 | 1,696 | $600K |
| 87536 | 10,282 | 9,939 | $570K | |
| 87340 | 84,782 | 82,637 | $568K | |
| 83550 | 105,454 | 102,285 | $551K | |
| 86780 | 55,719 | 54,281 | $501K | |
| 84702 | 48,262 | 38,530 | $489K | |
| 82670 | 28,150 | 27,158 | $476K | |
| 87070 | 80,873 | 77,643 | $472K | |
| 86235 | 9,694 | 7,945 | $461K | |
| 84481 | 45,749 | 44,305 | $448K | |
| 87186 | 79,948 | 74,892 | $446K | |
| 83540 | 109,042 | 105,747 | $427K | |
| 85027 | 110,558 | 105,747 | $423K | |
| 80074 | 15,607 | 15,017 | $406K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 7,778 | 6,930 | $398K |
| 81513 | 27,915 | 27,150 | $397K | |
| 87077 | 75,760 | 71,959 | $395K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 81,556 | 75,177 | $394K |
| 84153 | 36,530 | 35,255 | $377K | |
| 86704 | 44,481 | 43,158 | $344K | |
| 83970 | 15,502 | 14,699 | $338K | |
| 83001 | 27,062 | 26,309 | $322K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3,092 | 2,429 | $319K |
| 83880 | 14,821 | 13,897 | $314K | |
| 87512 | 10,877 | 10,431 | $308K | |
| 84402 | 18,108 | 17,400 | $277K | |
| 84146 | 22,217 | 21,400 | $275K | |
| 82570 | 90,343 | 86,037 | $275K | |
| 86038 | 33,947 | 32,777 | $269K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,616 | 1,563 | $266K |
| 86708 | 32,994 | 32,010 | $265K | |
| 86364 | 10,414 | 9,956 | $250K | |
| 83002 | 20,473 | 19,888 | $245K | |
| 86696 | 18,770 | 18,140 | $245K | |
| 86317 | 25,665 | 23,379 | $243K | |
| 83516 | 30,710 | 18,012 | $241K | |
| 82043 | 69,469 | 66,977 | $240K | |
| 86706 | 34,329 | 32,967 | $238K | |
| 86140 | 69,872 | 65,757 | $237K | |
| 84270 | 16,556 | 15,821 | $236K | |
| 86592 | 82,491 | 80,457 | $234K | |
| 88142 | 17,328 | 16,525 | $234K | |
| 87081 | 46,322 | 45,165 | $229K | |
| 82105 | 19,918 | 19,168 | $224K | |
| 86376 | 21,353 | 20,699 | $204K | |
| 87631 | 2,627 | 2,549 | $204K | |
| 84144 | 16,067 | 14,918 | $200K | |
| 86762 | 20,137 | 19,623 | $198K | |
| 82784 | 25,631 | 24,242 | $192K | |
| 86787 | 19,541 | 19,128 | $185K | |
| 82785 | 16,203 | 15,843 | $182K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 2,055 | 1,897 | $181K |
| 81001 | 85,707 | 81,602 | $173K | |
| 83655 | 20,715 | 20,350 | $171K | |
| 87209 | 13,699 | 10,942 | $169K | |
| 83735 | 40,863 | 36,563 | $165K | |
| 86695 | 17,512 | 16,936 | $163K | |
| 86800 | 15,503 | 15,053 | $161K | |
| 88141 | 11,051 | 10,851 | $159K | |
| 87529 | 5,379 | 3,304 | $159K | |
| 82627 | 10,346 | 10,061 | $153K | |
| 80055 | 5,967 | 5,798 | $150K | |
| 83520 | 14,717 | 10,785 | $144K | |
| 86850 | 25,053 | 24,665 | $142K | |
| 86200 | 16,115 | 15,753 | $137K | |
| 82950 | 36,845 | 36,001 | $129K | |
| 82677 | 6,764 | 6,537 | $122K | |
| 83690 | 27,329 | 26,313 | $121K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 5,499 | 3,331 | $120K |
| 80076 | 22,927 | 21,889 | $116K | |
| 87147 | 29,314 | 28,156 | $116K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,155 | 3,102 | $115K |
| 85652 | 63,887 | 61,027 | $114K | |
| 82951 | 11,492 | 11,300 | $109K | |
| 82533 | 10,258 | 9,634 | $106K | |
| 87338 | 11,834 | 11,328 | $106K | |
| 83993 | 8,563 | 8,332 | $103K | |
| 86147 | 4,622 | 2,087 | $100K | |
| 84436 | 27,256 | 26,582 | $98K | |
| 86665 | 4,614 | 4,351 | $96K | |
| 86258 | 2,039 | 1,911 | $95K | |
| 87075 | 14,977 | 14,264 | $94K | |
| 86146 | 4,274 | 1,899 | $94K | |
| 86008 | 4,381 | 3,532 | $94K | |
| 83525 | 12,435 | 11,584 | $93K | |
| 86431 | 24,999 | 24,341 | $92K | |
| 86360 | 2,971 | 2,797 | $92K | |
| 82274 | 9,769 | 9,409 | $91K | |
| 82652 | 7,782 | 7,318 | $90K | |
| 83921 | 7,646 | 7,343 | $88K | |
| 81596 | 3,604 | 3,506 | $84K | |
| 87177 | 13,678 | 10,924 | $84K | |
| 83090 | 7,970 | 7,644 | $83K | |
| 86141 | 9,753 | 9,465 | $82K | |
| 86160 | 5,772 | 5,314 | $82K | |
| 82542 | 5,717 | 5,030 | $81K | |
| 86769 | 3,028 | 2,922 | $80K | |
| 85610 | 31,822 | 27,928 | $79K | |
| 84480 | 11,825 | 11,483 | $79K | |
| 80164 | 10,609 | 9,825 | $78K | |
| 86336 | 6,813 | 6,586 | $77K | |
| 87517 | 2,704 | 2,607 | $75K | |
| 87427 | 9,641 | 9,390 | $75K | |
| 84479 | 19,910 | 19,443 | $74K | |
| 87255 | 3,272 | 3,188 | $72K | |
| 84550 | 25,840 | 24,504 | $72K | |
| 87481 | 2,594 | 1,671 | $69K | |
| 84154 | 6,609 | 6,364 | $68K | |
| 84425 | 5,287 | 5,084 | $68K | |
| 84445 | 2,068 | 1,982 | $67K | |
| 86039 | 9,076 | 8,727 | $66K | |
| 87449 | 8,918 | 7,733 | $64K | |
| 86765 | 7,273 | 7,005 | $63K | |
| 87045 | 9,983 | 9,722 | $63K | |
| 80178 | 15,969 | 14,677 | $63K | |
| 87205 | 22,536 | 21,423 | $63K | |
| 83521 | 1,130 | 1,063 | $63K | |
| 82653 | 957 | 923 | $62K | |
| 83498 | 3,303 | 3,225 | $61K | |
| 86361 | 3,434 | 3,279 | $60K | |
| 86735 | 6,486 | 6,225 | $58K | |
| 86225 | 6,325 | 6,076 | $56K | |
| 86812 | 3,495 | 3,391 | $55K | |
| 85060 | 6,194 | 6,010 | $55K | |
| 87493 | 2,300 | 2,225 | $54K | |
| 82977 | 12,417 | 11,955 | $54K | |
| 82150 | 12,315 | 11,932 | $52K | |
| 82024 | 2,080 | 2,001 | $52K | |
| 84681 | 3,961 | 3,785 | $52K | |
| 86255 | 7,325 | 4,830 | $51K | |
| 84156 | 21,359 | 19,586 | $51K | |
| 87329 | 6,190 | 6,004 | $49K | |
| 82248 | 17,681 | 15,547 | $49K | |
| 84207 | 2,605 | 2,516 | $46K | |
| 82672 | 3,230 | 3,092 | $45K | |
| 86900 | 21,840 | 21,351 | $45K | |
| 86901 | 21,871 | 21,375 | $45K | |
| 80069 | 9,736 | 8,979 | $44K | |
| 86334 | 2,923 | 2,781 | $42K | |
| 84165 | 6,003 | 5,777 | $41K | |
| 82088 | 1,554 | 1,466 | $41K | |
| 85730 | 11,460 | 10,994 | $38K | |
| 86664 | 3,946 | 3,806 | $38K | |
| 87046 | 5,796 | 5,543 | $38K | |
| 82172 | 3,502 | 3,372 | $38K | |
| 86705 | 4,773 | 4,670 | $37K | |
| 82530 | 2,754 | 1,837 | $37K | |
| 86870 | 1,460 | 1,420 | $37K | |
| 82378 | 3,271 | 2,860 | $37K | |
| 87324 | 4,869 | 4,702 | $36K | |
| 84100 | 14,554 | 12,501 | $36K | |
| 82247 | 12,576 | 9,419 | $36K | |
| 87625 | 1,879 | 1,743 | $36K | |
| 82550 | 8,812 | 8,110 | $36K | |
| 81329 | 1,273 | 1,234 | $35K | |
| 82140 | 4,078 | 3,690 | $35K | |
| 84305 | 2,460 | 2,401 | $35K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 629 | 614 | $34K |
| 81511 | 1,130 | 1,097 | $34K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 466 | 425 | $33K |
| 86381 | 1,171 | 1,137 | $33K | |
| 87563 | 1,786 | 1,702 | $33K | |
| 82565 | 11,430 | 10,613 | $33K | |
| 83721 | 7,780 | 7,554 | $33K | |
| 86231 | 1,980 | 1,851 | $32K | |
| 84630 | 4,457 | 4,306 | $32K | |
| 86341 | 3,064 | 1,667 | $31K | |
| 84460 | 9,578 | 9,018 | $31K | |
| 84703 | 6,054 | 5,808 | $30K | |
| 84482 | 2,775 | 2,724 | $29K | |
| 86304 | 2,351 | 2,203 | $28K | |
| 85007 | 12,078 | 11,692 | $28K | |
| 82330 | 3,353 | 3,193 | $28K | |
| 83615 | 7,152 | 6,439 | $27K | |
| 80175 | 3,193 | 3,074 | $27K | |
| 86162 | 1,936 | 1,895 | $27K | |
| 82040 | 8,336 | 7,882 | $26K | |
| 85379 | 3,983 | 3,727 | $26K | |
| 85045 | 9,341 | 9,054 | $26K | |
| 83519 | 2,552 | 1,478 | $25K | |
| 83704 | 1,706 | 1,673 | $25K | |
| 84450 | 7,090 | 6,703 | $24K | |
| 36416 | 5,592 | 4,500 | $24K | |
| 83020 | 2,573 | 2,531 | $24K | |
| 99001 | 16,455 | 12,842 | $23K | |
| 86036 | 1,022 | 978 | $23K | |
| 82525 | 2,871 | 2,722 | $23K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 248 | 235 | $23K |
| 87076 | 3,456 | 3,337 | $22K | |
| 85246 | 1,417 | 1,364 | $22K | |
| 86021 | 2,332 | 2,173 | $22K | |
| 82952 | 7,134 | 7,011 | $22K | |
| 84244 | 1,512 | 1,445 | $21K | |
| 85018 | 13,433 | 12,947 | $21K | |
| 82390 | 2,856 | 2,792 | $20K | |
| 80197 | 2,390 | 1,852 | $19K | |
| 85240 | 1,595 | 1,521 | $19K | |
| 85245 | 1,234 | 1,188 | $19K | |
| 86709 | 2,702 | 2,630 | $19K | |
| 83630 | 1,481 | 1,415 | $19K | |
| 86300 | 1,370 | 1,134 | $18K | |
| 86015 | 1,326 | 1,277 | $18K | |
| 80159 | 1,638 | 1,379 | $18K | |
| 81241 | 570 | 556 | $18K | |
| 80177 | 2,097 | 1,992 | $18K | |
| 82947 | 7,127 | 6,869 | $17K | |
| 99199 | Unlisted special service, procedure or report | 27,727 | 20,951 | $17K |
| 83014 | 3,085 | 3,015 | $17K | |
| 85014 | 10,308 | 9,938 | $16K | |
| 87800 | 805 | 789 | $16K | |
| 87535 | 752 | 710 | $16K | |
| 83835 | 1,400 | 1,276 | $16K | |
| 81015 | 7,442 | 7,224 | $15K | |
| 82310 | 5,264 | 5,068 | $15K | |
| 88342 | 389 | 298 | $15K | |
| 86618 | 1,264 | 1,218 | $14K | |
| 80156 | 1,919 | 1,791 | $14K | |
| 82103 | 1,556 | 1,499 | $13K | |
| 83695 | 2,910 | 2,803 | $13K | |
| 84432 | 1,280 | 1,214 | $13K | |
| 83698 | 859 | 837 | $13K | |
| 81381 | 196 | 64 | $13K | |
| 81025 | 2,562 | 2,363 | $13K | |
| 84484 | 1,690 | 1,629 | $13K | |
| 86359 | 605 | 571 | $13K | |
| 85613 | 1,920 | 1,840 | $13K | |
| 87901 | 72 | 67 | $12K | |
| 86308 | 3,462 | 3,364 | $12K | |
| 86645 | 1,101 | 1,061 | $12K | |
| 86593 | 4,049 | 3,884 | $12K | |
| 86644 | 1,224 | 1,182 | $12K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 42 | 38 | $11K |
| 84166 | 937 | 908 | $11K | |
| 86301 | 967 | 863 | $11K | |
| 84155 | 5,192 | 5,045 | $11K | |
| 82397 | 1,077 | 1,047 | $11K | |
| 84520 | 4,699 | 4,398 | $11K | |
| 83021 | 843 | 827 | $11K | |
| 87328 | 1,274 | 1,234 | $11K | |
| 84466 | 1,240 | 1,220 | $10K | |
| 83883 | 1,312 | 931 | $10K | |
| 86001 | 1,272 | 730 | $10K | |
| 82626 | 518 | 506 | $10K | |
| 81256 | 316 | 308 | $9K | |
| 87150 | 8,840 | 8,772 | $9K | |
| 80299 | 885 | 816 | $9K | |
| 86663 | 1,061 | 1,034 | $9K | |
| 83718 | 1,900 | 1,857 | $9K | |
| 82668 | 762 | 731 | $9K | |
| 84075 | 3,003 | 2,814 | $9K | |
| 82465 | 3,337 | 3,273 | $9K | |
| 84590 | 1,121 | 1,094 | $9K | |
| 81512 | 303 | 300 | $9K | |
| 82787 | 568 | 503 | $9K | |
| 87101 | 1,711 | 1,655 | $9K | |
| 84134 | 875 | 821 | $8K | |
| 86628 | 362 | 352 | $8K | |
| 87272 | 968 | 938 | $8K | |
| 86682 | 1,118 | 1,070 | $8K | |
| 87634 | 219 | 217 | $7K | |
| 85049 | 2,235 | 2,194 | $7K | |
| 85041 | 3,568 | 3,464 | $7K | |
| 83010 | 889 | 867 | $7K | |
| 87040 | 1,019 | 866 | $7K | |
| 87521 | Neg quan hep c or qual rna | 269 | 255 | $7K |
| 85247 | 449 | 434 | $7K | |
| 84132 | 2,349 | 2,194 | $7K | |
| 82747 | 684 | 666 | $7K | |
| 80185 | 978 | 882 | $6K | |
| 81003 | 4,512 | 4,242 | $6K | |
| 80051 | 1,467 | 1,396 | $6K | |
| 83825 | 560 | 535 | $6K | |
| 87900 | 72 | 67 | $6K | |
| 86753 | 605 | 569 | $6K | |
| 85004 | 1,603 | 1,501 | $6K | |
| 81291 | 772 | 758 | $6K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 143 | 142 | $5K |
| 84478 | 1,458 | 1,332 | $5K | |
| 82679 | 316 | 287 | $5K | |
| 87140 | 817 | 710 | $5K | |
| 81270 | 104 | 100 | $5K | |
| 82671 | 209 | 201 | $4K | |
| 84163 | 331 | 301 | $4K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 132 | 123 | $4K |
| 0001M | 452 | 436 | $4K | |
| 87102 | 738 | 716 | $4K | |
| 85306 | 395 | 380 | $4K | |
| 82166 | 168 | 160 | $4K | |
| 84446 | 441 | 429 | $4K | |
| 81206 | 50 | 49 | $4K | |
| 87185 | 1,204 | 1,151 | $4K | |
| 82175 | 312 | 299 | $4K | |
| 81243 | 154 | 154 | $4K | |
| 87254 | 204 | 180 | $4K | |
| 86702 | 500 | 472 | $3K | |
| 82164 | 358 | 348 | $3K | |
| 86774 | 344 | 339 | $3K | |
| 82384 | 193 | 188 | $3K | |
| 85048 | 2,102 | 1,969 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 321 | 311 | $3K |
| 81240 | 115 | 113 | $3K | |
| 85303 | 291 | 285 | $3K | |
| 82085 | 423 | 401 | $3K | |
| 88185 | 25 | 24 | $3K | |
| 86337 | 178 | 168 | $3K | |
| 84300 | 859 | 815 | $3K | |
| 86777 | 259 | 250 | $2K | |
| 84255 | 145 | 143 | $2K | |
| 87015 | 549 | 496 | $2K | |
| 87350 | 315 | 306 | $2K | |
| 86701 | 499 | 471 | $2K | |
| 87506 | 14 | 14 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 123 | 115 | $2K |
| 82340 | 593 | 578 | $2K | |
| 82705 | 631 | 606 | $2K | |
| 84260 | 91 | 90 | $2K | |
| 87632 | 14 | 14 | $2K | |
| 84295 | 710 | 544 | $2K | |
| 86648 | 180 | 176 | $2K | |
| 87999 | 84 | 83 | $2K | |
| 86778 | 170 | 161 | $2K | |
| 80183 | 247 | 239 | $2K | |
| 83497 | 173 | 172 | $2K | |
| 87206 | 408 | 348 | $2K | |
| 86707 | 197 | 192 | $2K | |
| 86382 | 95 | 95 | $1K | |
| 85300 | 174 | 171 | $1K | |
| 81443 | 14 | 14 | $1K | |
| 87906 | 14 | 14 | $1K | |
| 86256 | 130 | 124 | $1K | |
| 82365 | 143 | 135 | $1K | |
| 82656 | 148 | 140 | $1K | |
| 82239 | 103 | 100 | $1K | |
| 83935 | 234 | 228 | $1K | |
| 87280 | 114 | 114 | $1K | |
| 87220 | 363 | 350 | $1K | |
| 83918 | 78 | 76 | $1K | |
| 82157 | 55 | 53 | $1K | |
| 85651 | 668 | 594 | $986.09 | |
| 82104 | 99 | 99 | $971.63 | |
| 88230 | 12 | 12 | $883.84 | |
| 84311 | 245 | 237 | $863.02 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 1,897 | 1,746 | $841.14 |
| 87503 | 95 | 69 | $824.25 | |
| 88262 | 12 | 12 | $821.63 | |
| 82553 | 109 | 105 | $797.66 | |
| 81350 | 42 | 40 | $749.75 | |
| 82107 | 28 | 25 | $727.54 | |
| 80201 | 89 | 87 | $726.90 | |
| 89055 | 224 | 222 | $673.51 | |
| 88184 | 25 | 24 | $637.12 | |
| 80203 | 63 | 62 | $630.58 | |
| 83930 | 135 | 133 | $629.32 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 861 | 795 | $616.08 |
| 82731 | 12 | 12 | $596.70 | |
| 84252 | 44 | 42 | $580.33 | |
| 84597 | 62 | 62 | $578.91 | |
| 88304 | 26 | 24 | $561.15 | |
| 86316 | 38 | 37 | $549.18 | |
| 82435 | 255 | 249 | $527.54 | |
| 86041 | 13 | 13 | $524.62 | |
| 82374 | 208 | 204 | $472.10 | |
| 82610 | 37 | 37 | $455.45 | |
| 82978 | 43 | 43 | $424.92 | |
| 86060 | 100 | 92 | $422.61 | |
| 81479 | Unlisted molecular pathology procedure | 108 | 106 | $415.47 |
| 87109 | 116 | 108 | $393.02 | |
| 86880 | 110 | 105 | $372.60 | |
| 80165 | 132 | 123 | $362.43 | |
| 82495 | 28 | 27 | $354.75 | |
| 84591 | 92 | 81 | $341.42 | |
| 81508 | 13 | 13 | $325.84 | |
| 85597 | 27 | 27 | $317.24 | |
| 85384 | 53 | 51 | $302.83 | |
| 86611 | 41 | 13 | $298.13 | |
| 86148 | 32 | 14 | $290.20 | |
| 86335 | 13 | 13 | $274.93 | |
| 87106 | 46 | 41 | $263.92 | |
| 86738 | 13 | 12 | $236.20 | |
| 80162 | 40 | 37 | $216.07 | |
| 86671 | 24 | 13 | $216.07 | |
| 82726 | 13 | 12 | $189.00 | |
| 82725 | 13 | 12 | $176.80 | |
| 85660 | 52 | 50 | $171.23 | |
| 87116 | 19 | 13 | $154.63 | |
| 81227 | 42 | 40 | $153.90 | |
| 86905 | 55 | 50 | $140.30 | |
| 81226 | 42 | 40 | $137.88 | |
| 81335 | 43 | 41 | $116.59 | |
| 81306 | 42 | 40 | $105.33 | |
| 87425 | 12 | 12 | $100.57 | |
| 81247 | 42 | 40 | $100.35 | |
| 82955 | 14 | 13 | $97.96 | |
| 84087 | 24 | 17 | $96.18 | |
| 81225 | 42 | 40 | $90.00 | |
| 83992 | 35 | 28 | $88.11 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 98 | 95 | $72.36 |
| 81283 | 42 | 40 | $65.07 | |
| 80324 | 1,070 | 800 | $62.64 | |
| 89051 | 12 | 12 | $54.22 | |
| 87184 | 12 | 12 | $48.22 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 1,411 | 1,297 | $44.57 |
| 80354 | 1,113 | 883 | $42.00 | |
| 80348 | 517 | 329 | $39.10 | |
| 84133 | 12 | 12 | $36.11 | |
| 80323 | 214 | 143 | $33.94 | |
| 80358 | 1,184 | 876 | $32.79 | |
| 80349 | 1,819 | 1,247 | $12.08 | |
| 80337 | 34 | 27 | $3.78 | |
| 80370 | 34 | 27 | $3.46 | |
| 80365 | 1,155 | 782 | $3.39 | |
| 80361 | 1,176 | 803 | $3.39 | |
| 80356 | 72 | 47 | $3.39 | |
| 80326 | 34 | 27 | $3.25 | |
| 80346 | 1,077 | 758 | $3.22 | |
| 80360 | 140 | 99 | $3.15 | |
| 80338 | 34 | 27 | $3.15 | |
| 80321 | 196 | 135 | $3.15 | |
| 80368 | 34 | 27 | $3.15 | |
| 80377 | 34 | 27 | $2.18 | |
| 80345 | 50 | 42 | $2.00 | |
| 80320 | 56 | 45 | $1.89 | |
| 81232 | 42 | 40 | $0.00 | |
| 81355 | 42 | 40 | $0.00 | |
| 80355 | 19 | 13 | $0.00 | |
| 80375 | 455 | 352 | $0.00 | |
| 80373 | 112 | 92 | $0.00 | |
| 80364 | 461 | 352 | $0.00 | |
| 80366 | 19 | 13 | $0.00 | |
| 80369 | 14 | 14 | $0.00 | |
| 81328 | 42 | 40 | $0.00 | |
| 80372 | 19 | 13 | $0.00 | |
| 80344 | 19 | 13 | $0.00 | |
| 80371 | 441 | 338 | $0.00 | |
| 80352 | 441 | 338 | $0.00 | |
| 81230 | 42 | 40 | $0.00 | |
| 80329 | 12 | 12 | $0.00 | |
| 81231 | 42 | 40 | $0.00 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 37 | 37 | $0.00 |
| 81400 | 42 | 40 | $0.00 | |
| 85008 | 72 | 64 | $0.00 | |
| 80353 | 19 | 13 | $0.00 | |
| 80333 | 19 | 13 | $0.00 | |
| 80359 | 19 | 13 | $0.00 | |
| 80357 | 19 | 13 | $0.00 | |
| 80330 | 19 | 13 | $0.00 | |
| 80367 | 19 | 13 | $0.00 | |
| 80340 | 19 | 13 | $0.00 |